According to SEC filings for the period ending December 2025, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) is held by 32 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 30 Sep, 2025 | 12,466,489 | 0 | 0.00% | $146,730,576.00 |
| Medicxi Ventures Management (Jersey) Ltd | 30 Sep, 2025 | 7,464,572 | 0 | 0.00% | $87,858,012.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 5,081,451 | 2,830,954 | 125.79% | $59,808,678.00 |
| Invesco Ltd. | 30 Sep, 2025 | 3,864,971 | -275,101 | -6.64% | $45,490,710.00 |
| Carlyle Group Inc. | 30 Sep, 2025 | 3,496,808 | 0 | 0.00% | $41,052,526.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,402,324 | 86,976 | 2.62% | $40,045,354.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 3,215,572 | 428,261 | 15.36% | $37,847,282.00 |
| Ensign Peak Advisors, Inc | 30 Sep, 2025 | 2,503,344 | -16,628 | -0.66% | $29,464,359.00 |
| NEA Management Company, LLC | 30 Sep, 2025 | 1,960,169 | 0 | 0.00% | $23,071,189.00 |
| 683 Capital Management, LLC | 30 Sep, 2025 | 1,820,380 | -284,620 | -13.52% | $21,425,873.00 |
| WASATCH ADVISORS LP | 30 Sep, 2025 | 1,537,218 | 75,323 | 5.15% | $18,093,056.00 |
| Catalys Pacific, LLC | 30 Sep, 2025 | 1,167,114 | 0 | 0.00% | $13,736,932.00 |
| GW&K Investment Management, LLC | 30 Sep, 2025 | 1,144,330 | 95,858 | 9.14% | $13,469.00 |
| Catalio Capital Management, LP | 30 Sep, 2025 | 1,128,521 | 456,231 | 67.86% | $13,282,692.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,088,910 | 18,983 | 1.77% | $12,819,107.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,053,591 | 204,167 | 24.04% | $12,400,766.00 |
| Caption Management, LLC | 30 Sep, 2025 | 1,000,000 | 184,900 | 22.68% | $11,770,000.00 |
| MOORE CAPITAL MANAGEMENT, LP | 30 Sep, 2025 | 600,000 | 0 | 0.00% | $7,062,000.00 |
| AMERIPRISE FINANCIAL INC | 30 Sep, 2025 | 554,590 | 373,739 | 206.66% | $6,527,524.00 |
| Propel Bio Management, LLC | 30 Sep, 2025 | 552,927 | -370,000 | -40.09% | $6,507,951.00 |